Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Expression and Production of Human Granulocyte Colony Stimulating Factor (G-CSF) in Silkworm Cell Line

누에세포를 이용한 인간 G-CSF의 발현 및 생산

  • Park, Jeong-Hae (Department of Clinical Laboratory Science, Dong Eui University) ;
  • Jang, Ho-Jung (Department of Clinical Laboratory Science, Dong Eui University) ;
  • Kang, Seok-Woo (Department of Agricultural Biology, National Academy of Agricultural Science, RDA) ;
  • Goo, Tae-Won (Department of Agricultural Biology, National Academy of Agricultural Science, RDA) ;
  • Chung, Kyung-Tae (Department of Clinical Laboratory Science, Dong Eui University)
  • 박정혜 (동의대학교 임상병리학과) ;
  • 장호정 (동의대학교 임상병리학과) ;
  • 강석우 (국립농업과학원 농업생물부) ;
  • 구태원 (국립농업과학원 농업생물부) ;
  • 정경태 (동의대학교 임상병리학과)
  • Received : 2010.06.03
  • Accepted : 2010.11.24
  • Published : 2010.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Granulocyte colony stimulating factor (G-CSF) is a hematopoietic cytokine that stimulates bone marrow cells to proliferate and differentiate into granulocytes. G-CSF is approved and used for therapeutic purposes. The endoplasmic reticulum (ER) signal peptide of hG-CSF was replaced with silkworm-specific signal peptides to express and efficiently secrete recombinant hG-CSF by silkworm cells. Plasmids that contain cDNAs for hG-CSF and hG-CSF fused with silkworm- specific signal peptides of prophenoloxidase activating enzyme (PPAE), protein disulfide isomerase (PDI), and bombyxin (BX) were constructed. The G-CSF protein was expressed in insect cell line BM5 and was detected by western blot analysis. The cells transfected with plasmids containing rhG-CSF genes with silkworm-specific signal sequences released mature rhG-CSF protein more efficiently than the cells transfected with pG-CSF, the plasmid containing human G-CSF gene, including its own signal sequence. The production of hG-CSF reached maximal level at four days post-transfection and remained at a high level until 7 days post-transfection. These data demonstrate that the modification of the human G-CSF mimic to insect proteins synthesized in ER greatly improves the production of the protein.

조혈촉진 cytokine인 Granulocyte colony stimulating factor (G-CSF)는 골수세포를 자극하여 granulocyte로 증식, 분화시키는 기능을 가지며, 현재 아주 고가의 치료제로 사용되고 있다. 인간 G-CSF (hG-CSF)를 아직 시도되지 않은 누에 유래 세포주인 BM5 세포에서 발현시키고 생산 효율을 높이기 위해 hG-CSF cDNA를 변형하였다. hG-CSF의 cDNA의 endoplasmic reticulum (ER) signal sequence 부분을 누에의 소포체에서 분비되는 단백질인 prophenoloxidase (PPAE), protein disulfide isomerase (PDI)와 bombyxin (BX)에서 유래한 누에특이 ER signal sequence로 대체한 hG-CSF의 cDNA 함유 벡터를 구축하였다. 이들 벡터를 사용하여 형질전환한 BM5 세포의 배양액에 분비된 G-CSF 단백질을 western blot으로 분석하여 발현을 확인하였다. 누에특이 ER signal sequence들로 대체된 hG-CSF cDNA를 포함하는 벡터에 의한 hG-CSF 단백질 생산이 인간 G-CSF cDNA가 든 벡터에 의한 hG-CSF의 생산보다 월등히 효율적이었다. 또한, PPAE-signal sequence를 포함하는 hG-CSF 단백질은 배양배지에서 형질전환 4일 후에 최고에 달하였고, 7 일째까지 비슷한 양이 배지 내에서 검출되었다. 이상의 결과는 인간유래 유전자가 곤충세포 내에서 발현 될 때 인간유래 유전자 보다는 곤충 유전자발현 시스템에 맞게 변형했을 경우 더 효율적인 단백질 발현을 얻을 수 있음을 보여 준다.

Keywords

References

  1. Bendtsen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340, 783-795. https://doi.org/10.1016/j.jmb.2004.05.028
  2. Carter, C. R. D., J. R. Keeble, and R. Thorpe. 2004. Human serum inactivates non-glycosylated but not glycosylated granulocyte colony stimulating factor by a protease dependent mechanism: significance of carbohydrates on the glycosylated molecule. Biologicals 32, 37-47. https://doi.org/10.1016/j.biologicals.2003.12.002
  3. Frampton, J. E., C. R. Lee, and D. Faulds. 1994. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48, 731-760. https://doi.org/10.2165/00003495-199448050-00007
  4. Herrmann, F., A. Lindemann, and R. Mertelsmann. 1990. G-CSF and M-CSF: from molecular biology to clinical application. Biotherapy 2, 315-324. https://doi.org/10.1007/BF02170081
  5. Hoguland, M . 1998. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference? Med. Oncol. 15, 229-233. https://doi.org/10.1007/BF02787205
  6. Hubel, K., D. C. Dale, A. Engart., and W. C. Liles. 2000. Use of G-CSF for granulocyte transfusion therapy. Cytokines Cell Mol. Ther. 6, 89-95. https://doi.org/10.1080/13684730050515813
  7. Kubota, N., T. Orita, K. Hattori, M. Oh-eda, N. Ochi, and T. Yamazaki. 1990. Structural characterization of natural and recombinant human granulocyte colony-stimulating factors. J. Biochem. 107, 280-286.
  8. Nicola, N. A. and D. Metcalf. 1984. Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines. Proc. Natl. Acad. Sci. USA 12, 3765-3769.
  9. Nicola, N. A. and D. Metcalf. 1985. The colony-stimulating factors and myeloid leukemia. Cancer Surv. 4, 789-815.
  10. Oh-eda, M., M. Hasegawa, K. Hattori, H. Kuboniwa, T. Kojima, T. Orita, K. Tomonou, T. Yamazaki, and N. Ochi. 1990. Granulocyte Colony-stimulating Factor Protects It against Polymerization and Denaturation Allowing It to Retain Its Biological Activity. J. Biol. Chem. 265, 11432-11435.
  11. Price, T. H. 2002. Granulocyte transfusion in the G-CSF era. Int. J. Hematol. 76 Suppl 2, 77-80. https://doi.org/10.1007/BF03165092
  12. Souza, L. M., T. C. Boone, J. Gabrilove, P. H. Lai, K. M. Zsebo, D. C. Murdock, V. R. Chazin, J. Bruszewski, H. Lu, and K. K. Chen. 1986. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232, 61-65. https://doi.org/10.1126/science.2420009
  13. Sassenfeld, H. 1991. Purification of G-CSF. Patent US5,055,555.
  14. Spiekermann, K., J. Roesler, A. Emmendoerffer, J. Elsner, and K. Welte. 1997. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia 11, 466-478. https://doi.org/10.1038/sj.leu.2400607
  15. U.S Food & Drug Administration. U.S Department of Health and Human Services Therapeutic Biological Products Approvals. (http://www.accessdata.fda.gov/scripts/cder/onctools/druglist.cfm)
  16. Visani, G., and S. Manfroi. 1995. G-CSF in the biology and treatment of acute myeloid leukemias. Leuk. Lymphoma 18, 423-428. https://doi.org/10.3109/10428199509059640
  17. Vanz, A. L. S., G. Rnard, M. S. Palma, J. M. Chies, S. L. Dalmora, L. A. Basso, and D. S. Santos. 2008. Human granulocyte colony stimulating factor (hG-CSF):cloning, overexpression, purification and characterization. Microb. Cell Factories 7, 13. https://doi.org/10.1186/1475-2859-7-13

Cited by

  1. Modulation of G-CSF Secretion by Mutations of Non Alpha-Helical Region in N-Terminus vol.21, pp.12, 2011, https://doi.org/10.5352/JLS.2011.21.12.1778